Literature DB >> 17931207

Pathology and immunopathology of immunoglobulin G4-related sclerosing cholangitis: The latest addition to the sclerosing cholangitis family.

Yasuni Nakanuma1, Yoh Zen.   

Abstract

Sclerosing cholangitis is heterogeneous in its etiopathogenesis. Recently, sclerosing cholangitis showing abundant immunoglobulin (Ig)G4+ plasma cell infiltration was added to the sclerosing cholangitis group. This form was frequently associated with sclerosing pancreatitis (autoimmune pancreatitis) and also occasionally with other diseases such as chronic sclerosing sialadenitis, all of which falls within IgG4-related sclerosing disease. Herein, this new member, called IgG4-related sclerosing cholangitis (IgG4-SC), is reviewed. IgG4-SC shows grossly medullary and fleshy lesions along the biliary tree, and histologically marked lymphoplasmacytic infiltration with extensive fibrosis, and obliterative phlebitis, sharing histopathological features with sclerosing pancreatitis. Peribiliary glands are also severely affected. Interestingly, hepatic inflammatory pseudotumor (HIP) is not infrequently associated with IgG4-SC, and is thought as a local exaggeration of IgG4-SC. Immunohistochemically, many IgG4+ plasma cells and CD4+/CD25+ regulatory T cells are found around the affected bile ducts and portal tracts. Incontrast, these cells are scarce in the affected bile ducts of primary sclerosing cholangitis (PSC), a prototype of sclerosing cholangitis. Biliary lining epithelia are relatively spared in IgG4-SC in comparison with those of PSC showing degeneration and ulceration. In some cases of IgG4-SC, IgG4+ plasma cells are also found considerably in small portal tracts, so needle liver biopsy is useful for the diagnosis of IgG4-SC. Therapeutically, IgG4-SC responds well to steroid therapy, while such character is not reported in PSC. Taken together, IgG4-SC may be etiologically different from PSC, and immunopathological processes relating to IgG4 and regulatory T cells may be involved in the pathogenesis of IgG4-SC. Further studies are needed to clarify the etiopathogenesis of IgG4-SC and its related disorders.

Entities:  

Year:  2007        PMID: 17931207     DOI: 10.1111/j.1872-034X.2007.00243.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  15 in total

1.  Hypocomplementemia of unknown etiology: an opportunity to find cases of IgG4-positive multi-organ lymphoproliferative syndrome.

Authors:  Takako Saeki; Tomoyuki Ito; Hajime Yamazaki; Naofumi Imai; Shinichi Nishi
Journal:  Rheumatol Int       Date:  2009-11       Impact factor: 2.631

2.  Pathological classification of intrahepatic cholangiocarcinoma based on a new concept.

Authors:  Yasuni Nakanuma; Yasunori Sato; Kenichi Harada; Motoko Sasaki; Jing Xu; Hiroko Ikeda
Journal:  World J Hepatol       Date:  2010-12-27

Review 3.  IgG4-related hepatobiliary disease: an overview.

Authors:  Emma L Culver; Roger W Chapman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-09-14       Impact factor: 46.802

4.  Induction of IgA and sustained deficiency of cell proliferative response in chronic hepatitis C.

Authors:  Yalena Amador-Cañizares; Liz Alvarez-Lajonchere; Ivis Guerra; Ingrid Rodríguez-Alonso; Gillian Martínez-Donato; Julián Triana; Eddy E González-Horta; Angel Pérez; Santiago Dueñas-Carrera
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

5.  Sclerosing cholangitis associated with retroperitoneal fibrosis: a case of multisystem fibroinflammatory disorder.

Authors:  Grazyna T Rompa; Anna K Jablonska; Marek T Guzek; Michal M Dubowik; Iwona E Marek; Marian K Smoczynski
Journal:  Hepatol Int       Date:  2010-10-07       Impact factor: 6.047

Review 6.  Usefulness of steroid administration for diagnosis of IgG4-related sclerosing cholangitis.

Authors:  Norio Kubo; Hideki Suzuki; Tsutomu Kobayashi; Kenichiro Araki; Shigeru Sasaki; Wataru Wada; Hiroyuki Kuwano
Journal:  Int Surg       Date:  2012 Apr-Jun

Review 7.  IgG4-related sclerosing disease.

Authors:  Terumi Kamisawa; Atsutake Okamoto
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

8.  Diagnostic Dilemma in a Patient with Jaundice: How to Differentiate between Autoimmune Pancreatitis, Primary Sclerosing Cholangitis and Pancreas Carcinoma.

Authors:  Matthias Buechter; Christian Georg Klein; Christian Kloeters; Guido Gerken; Ali Canbay; Alisan Kahraman
Journal:  Case Rep Gastroenterol       Date:  2012-04-30

Review 9.  IgG4-related sclerosing disease, an emerging entity: a review of a multi-system disease.

Authors:  Mukul Divatia; Sun A Kim; Jae Y Ro
Journal:  Yonsei Med J       Date:  2012-01       Impact factor: 2.759

Review 10.  Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis.

Authors:  Samantha Sarcognato; Diana Sacchi; Federica Grillo; Nora Cazzagon; Luca Fabris; Massimiliano Cadamuro; Ivana Cataldo; Claudia Covelli; Alessandra Mangia; Maria Guido
Journal:  Pathologica       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.